Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients

Daisuke Ota, Koshi Mimori, Takehiko Yokobori, Masaaki Iwatsuki, Akemi Kataoka, Norikazu Masuda, Hideshi Ishii, Shinji Ohno, Masaki Mori

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Recently, bone marrow has been considered as playing a critical role in the generation of both metastasis and recurrent disease. The accumulation of a single microRNA in the bone marrow has the potential to regulate the translation of multiple genes in cancer metastasis and may therefore serve as a prognostic marker for cancer recurrence. MicroRNA micro-array analysis was performed to compare microRNA levels in bone marrow from 4 breast cancer patients with recurrent disease and 4 patients without recurrence. Accumulation of two of these microRNAs, miR-21 and miR-181a, in the recurrent breast cancer cases was validated by RT-PCR in bone marrow from 291 additional breast cancer cases. Expression of a common target gene, PDCD4, was also determined in bone marrow from 291 breast cancer cases. Increased miR-21 and miR-181a levels were significantly associated with shortened disease-free survival (DFS; p=0.0003, 0.0007) and overall survival (OS; p=0.0351, 0.0443), respectively. While low PDCD4 expression was also significantly associated with poorer DFS (p=0.036). Multivariate analysis identified bone marrow miR-21 and mR-181a levels as valuable independent prognostic factors, with correlation coefficients that were significantly higher than that of the transcript of their common target gene. Accumulation of miR-21 and miR-181a in bone marrow appears to be associated with prognosis in breast cancer patients. The much higher significant correlation with microRNA levels and prognosis suggests epistatic effects on multiple target genes in the bone marrow of breast cancer patients.

Original languageEnglish
Pages (from-to)955-962
Number of pages8
JournalInternational journal of oncology
Volume38
Issue number4
DOIs
Publication statusPublished - Apr 1 2011

Fingerprint

MicroRNAs
Bone Marrow
Breast Neoplasms
Recurrence
Neoplasm Metastasis
Genes
Neoplasm Genes
Disease-Free Survival
Multivariate Analysis
Polymerase Chain Reaction
Survival
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. / Ota, Daisuke; Mimori, Koshi; Yokobori, Takehiko; Iwatsuki, Masaaki; Kataoka, Akemi; Masuda, Norikazu; Ishii, Hideshi; Ohno, Shinji; Mori, Masaki.

In: International journal of oncology, Vol. 38, No. 4, 01.04.2011, p. 955-962.

Research output: Contribution to journalArticle

Ota, Daisuke ; Mimori, Koshi ; Yokobori, Takehiko ; Iwatsuki, Masaaki ; Kataoka, Akemi ; Masuda, Norikazu ; Ishii, Hideshi ; Ohno, Shinji ; Mori, Masaki. / Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. In: International journal of oncology. 2011 ; Vol. 38, No. 4. pp. 955-962.
@article{654339cd06c942339c11ea2453b4d18a,
title = "Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients",
abstract = "Recently, bone marrow has been considered as playing a critical role in the generation of both metastasis and recurrent disease. The accumulation of a single microRNA in the bone marrow has the potential to regulate the translation of multiple genes in cancer metastasis and may therefore serve as a prognostic marker for cancer recurrence. MicroRNA micro-array analysis was performed to compare microRNA levels in bone marrow from 4 breast cancer patients with recurrent disease and 4 patients without recurrence. Accumulation of two of these microRNAs, miR-21 and miR-181a, in the recurrent breast cancer cases was validated by RT-PCR in bone marrow from 291 additional breast cancer cases. Expression of a common target gene, PDCD4, was also determined in bone marrow from 291 breast cancer cases. Increased miR-21 and miR-181a levels were significantly associated with shortened disease-free survival (DFS; p=0.0003, 0.0007) and overall survival (OS; p=0.0351, 0.0443), respectively. While low PDCD4 expression was also significantly associated with poorer DFS (p=0.036). Multivariate analysis identified bone marrow miR-21 and mR-181a levels as valuable independent prognostic factors, with correlation coefficients that were significantly higher than that of the transcript of their common target gene. Accumulation of miR-21 and miR-181a in bone marrow appears to be associated with prognosis in breast cancer patients. The much higher significant correlation with microRNA levels and prognosis suggests epistatic effects on multiple target genes in the bone marrow of breast cancer patients.",
author = "Daisuke Ota and Koshi Mimori and Takehiko Yokobori and Masaaki Iwatsuki and Akemi Kataoka and Norikazu Masuda and Hideshi Ishii and Shinji Ohno and Masaki Mori",
year = "2011",
month = "4",
day = "1",
doi = "10.3892/ijo.2011.926",
language = "English",
volume = "38",
pages = "955--962",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients

AU - Ota, Daisuke

AU - Mimori, Koshi

AU - Yokobori, Takehiko

AU - Iwatsuki, Masaaki

AU - Kataoka, Akemi

AU - Masuda, Norikazu

AU - Ishii, Hideshi

AU - Ohno, Shinji

AU - Mori, Masaki

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Recently, bone marrow has been considered as playing a critical role in the generation of both metastasis and recurrent disease. The accumulation of a single microRNA in the bone marrow has the potential to regulate the translation of multiple genes in cancer metastasis and may therefore serve as a prognostic marker for cancer recurrence. MicroRNA micro-array analysis was performed to compare microRNA levels in bone marrow from 4 breast cancer patients with recurrent disease and 4 patients without recurrence. Accumulation of two of these microRNAs, miR-21 and miR-181a, in the recurrent breast cancer cases was validated by RT-PCR in bone marrow from 291 additional breast cancer cases. Expression of a common target gene, PDCD4, was also determined in bone marrow from 291 breast cancer cases. Increased miR-21 and miR-181a levels were significantly associated with shortened disease-free survival (DFS; p=0.0003, 0.0007) and overall survival (OS; p=0.0351, 0.0443), respectively. While low PDCD4 expression was also significantly associated with poorer DFS (p=0.036). Multivariate analysis identified bone marrow miR-21 and mR-181a levels as valuable independent prognostic factors, with correlation coefficients that were significantly higher than that of the transcript of their common target gene. Accumulation of miR-21 and miR-181a in bone marrow appears to be associated with prognosis in breast cancer patients. The much higher significant correlation with microRNA levels and prognosis suggests epistatic effects on multiple target genes in the bone marrow of breast cancer patients.

AB - Recently, bone marrow has been considered as playing a critical role in the generation of both metastasis and recurrent disease. The accumulation of a single microRNA in the bone marrow has the potential to regulate the translation of multiple genes in cancer metastasis and may therefore serve as a prognostic marker for cancer recurrence. MicroRNA micro-array analysis was performed to compare microRNA levels in bone marrow from 4 breast cancer patients with recurrent disease and 4 patients without recurrence. Accumulation of two of these microRNAs, miR-21 and miR-181a, in the recurrent breast cancer cases was validated by RT-PCR in bone marrow from 291 additional breast cancer cases. Expression of a common target gene, PDCD4, was also determined in bone marrow from 291 breast cancer cases. Increased miR-21 and miR-181a levels were significantly associated with shortened disease-free survival (DFS; p=0.0003, 0.0007) and overall survival (OS; p=0.0351, 0.0443), respectively. While low PDCD4 expression was also significantly associated with poorer DFS (p=0.036). Multivariate analysis identified bone marrow miR-21 and mR-181a levels as valuable independent prognostic factors, with correlation coefficients that were significantly higher than that of the transcript of their common target gene. Accumulation of miR-21 and miR-181a in bone marrow appears to be associated with prognosis in breast cancer patients. The much higher significant correlation with microRNA levels and prognosis suggests epistatic effects on multiple target genes in the bone marrow of breast cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=79952320057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952320057&partnerID=8YFLogxK

U2 - 10.3892/ijo.2011.926

DO - 10.3892/ijo.2011.926

M3 - Article

C2 - 21271219

AN - SCOPUS:79952320057

VL - 38

SP - 955

EP - 962

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 4

ER -